A series of thienopyridinone derivatives was designed and synthesized as inhibitors of checkpoint kinase 1 (Chk1). Most of them exhibited moderate to good Chk1 inhibitory activities. Among them, compounds 8q, 8t, and 8w with excellent Chk1 inhibitory activities (IC50 values of 4.05, 6.23, and 2.33nM, respectively) displayed strong synergistic effects with melphalan, a DNA-damaging agent in the cell-based assay. Further kinase profiling indicated that compound 8t was highly selective against CDK2/cyclinA, Aurora A, and PKC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2014.06.044 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
study of novel coumarin derivatives as potential agents in the pancreatic cancer treatment.
Comput Methods Biomech Biomed Engin
November 2024
Department of Natural Science and Mathematics, State University of Novi Pazar, Novi Pazar, Serbia.
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest diseases. Here are investigated two synthesized and two hypothetical coumarin derivatives, and their capacity to be used in the PDAC targeted treatment. The inhibitory activity of these four molecules against PARP, ATM, and CHK1 proteins responsible for DNA molecule repair was examined by docking and molecular dynamic analysis.
View Article and Find Full Text PDFInflammasome protein scaffolds the DNA damage complex during tumor development.
Nat Immunol
November 2024
Division of Immunology and Infectious Diseases, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.
Article Synopsis
- Inflammasome proteins, like NLRC4, play a role in controlling inflammation and cell death, but also impact diseases in ways other than their typical functions.
- Research shows that NLRC4 can help reduce tumor development in a specific mouse model, independently of other inflammasome proteins.
- NLRC4 works with a complex involved in DNA damage response, promoting mechanisms that activate checkpoint proteins to prevent cancer by managing DNA damage effectively.*
Harnessing the synergy of nanosecond high-power microwave pulses and cisplatin to increase the induction of apoptosis in cancer cells through the activation of ATR/ATM and intrinsic pathways.
Free Radic Biol Med
November 2024
Department of Plasma Bio Display, Kwangwoon University, Seoul, South Korea; Plasma Bioscience Research Center (PBRC), Kwangwoon University, Seoul, South Korea; Department of Electrical and Biological Physics, Kwangwoon University, Seoul, South Korea. Electronic address:
The therapeutic application and dose of cisplatin are limited due to its toxicity to normal cells. Therefore, combination treatments might be the solution with a low dose of cisplatin. The combination effect of nanosecond pulsed high-power microwave (HPM) with cisplatin has not been investigated before.
View Article and Find Full Text PDFCombination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells.
Cancer Chemother Pharmacol
December 2024
Center for Education and Research on Clinical Pharmacy, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo, 194-8543, Japan.
Purpose: In our previous study, we found that the Chk1 inhibitor prexasertib enhances the antitumour effect of the oral anticancer drug S-1 against pancreatic cancer cells. In this study, we investigated the effect of combining S-1 and ceralasertib, an oral inhibitor of ATR, which is located upstream of Chk1. Ceralasertib is currently being investigated in multiple clinical trials for various cancers.
View Article and Find Full Text PDFNovel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights.
Bioorg Chem
August 2024
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Nasr City 11754, Cairo, Egypt. Electronic address:
Applying various drug design strategies including ring variation, substituents variation, and ring fusion, two series of 2-(alkylthio)-5-(arylidene/heteroarylidene)imidazolones and imidazo[1,2-a]thieno[2,3-d]pyrimidines were designed and prepared as dual potential Chk1 and Chk2 inhibitors. The newly synthesized hybrids were screened in NCI 60 cell line panel where the most active derivatives 4b, d-f, and 6a were further estimated for their five dose antiproliferative activity against the most sensitive tumor cells including breast MCF-7 and MDA-MB-468 and non-small cell lung cancer EKVX as well as normal WI-38 cell. Noticeably, increasing the carbon chain attached to thiol moiety at C-2 of imidazolone scaffold elevated the cytotoxic activity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!